<DOC>
	<DOCNO>NCT02736240</DOCNO>
	<brief_summary>The purpose study investigate valuate immunogenicity safety 13-valent pneumococcal polysaccharide conjugate vaccine 2-71 month old healthy infant toddler ( young could 6 week old )</brief_summary>
	<brief_title>Immunogenicity Safety Study 13-valent Pneumococcal Polysaccharide Conjugate Vaccine 2-71 Months Old Healthy Infants Toddlers ( Youngest Could 6 Weeks Old )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>271 month ( young could 6 week old ) infants toddler positively healthy base medical history , physical examination judgment investigator ; The statutory guardian ( consignor ) subject agree his/her child participate study , willing sign inform consent form ; The subject his/her statutory guardian ( consignor ) able comply request clinical study protocol ; Never immunize pneumococcus vaccine , n't get immunization preventive product past 10 day ( n't get immunized attenuate live vaccine past 14 day ) ; The auxillary temperature ≤37℃ . Has already immunize pneumococcus vaccine matter experimental market ; With history invasive disease cause streptococcus pneumonia culture ; With history serious allergy vaccine drug , get fever high 39℃ related immunization preventive biological product ; Infant birth weight light 2.5 kg ; With history family history seizure , epilepsy , cerebropathy psychosis ; Infant abnormal labor ( difficult labor , deliver apparatus ) history asphyxia nervous damage ; With history thrombocytopenia coagulation disorder definite diagnosis ; Infant toddler pathological jaundice diagnosis ; Be know suspected immunological dysfunction , include immunosuppressive therapy ( radiotherapy , chemotherapy , corticosteroid hormone , antimetabolite , cytotoxic drug ) , HIV infection etc . ; Be know serious congenital malformation serious chronic disease ; suffer congenital malformation diagnose serious chronic disease ( eg . Down syndrome , diabetes mellitus , sickle cell anemia nervous disease , GuillainBarre syndrome ) ; Be know suspected disease include : disease respiratory system , acute infection active period chronic disease , serious cardiovascular disease , hepaticnephrotic disease , malignant tumor , skin disease ; Has take blood product globulin ( hepatitis B immune globulin allow ) ; Be participate clinical trial ; Any situation consider influence evaluation study investigator .</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>71 Months</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>